News and Events2026-03-30T11:20:27-04:00

News and Events

ABC Joins Bipartisan Lawmakers to Relaunch Congressional PAD Caucus

The Association of Black Cardiologists (ABC) joined bipartisan members of Congress, leading medical societies, and patient advocates in Washington for the relaunch of the Congressional Peripheral Artery Disease (PAD) Caucus, a critical step forward in addressing one of the nation’s most underdiagnosed and undertreated cardiovascular conditions. Hosted by Representatives Gus Bilirakis (R-FL) and Sheila Cherfilus-McCormick (D-FL), the event... Read More

February 13, 2026|General News, Latest News|

ABC American Heart Month 2026 Advancing Heart Health Where It’s Needed Most

February is American Heart Month—and the Association of Black Cardiologists (ABC) is meeting communities where they are to confront cardiovascular disease, expand access to care, and advance health equity. Throughout February, ABC is engaging clinicians, community leaders, faith-based partners, and patients through educational forums, screenings, and community-centered events focused on prevention, awareness, and action—particularly in regions facing cardiology... Read More

February 2, 2026|Events, General News, Latest News|

New On-Demand CME Courses Now Available: Advancing Care in Heart Failure, Diabetes, and Hypertension

The ABC is pleased to announce the availability of a new series of on-demand CME/CE courses designed to support clinicians in addressing complex, high-impact cardiovascular conditions. Developed in collaboration with an educational partner and supported through dedicated grant funding, these courses focus on closing treatment gaps and strengthening clinical approaches to conditions that disproportionately affect Black and... Read More

January 6, 2026|General News, Latest News|

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten), 5 mg, 10 mg, 15 mg, 20 mg tablets for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is an allosteric and reversible inhibitor of cardiac myosin motor activity. In patients... Read More

December 23, 2025|Latest News, Press Releases|

Thank You for Celebrating 50 Years With Us!

Thank you for helping make ABC’s Golden Celebration Weekend a meaningful milestone. Your support allowed us to honor our founder and founding members, elevate critical conversations on maternal health equity and public policy, and engage our next generation of leaders with didactic and immersive experiences. We’re grateful to have you with us as we begin the next... Read More

November 25, 2025|Events, General News, Latest News|

Upcoming Events

Go to Top